Investors gained access to a new international play on the Canadian Securities Exchange (CSE) as Israel-based medical marijuana producer and researcher IM Cannabis (IMC) (CSE:IMCC) officially launched on the exchange.

IMC started trading on Tuesday (November 5) under the ticker symbol “IMCC.” Shares of IMC opened at C$0.75 that day; as of 11:54 a.m. EST, the company was up 0.67 percent.

The company raised approximately C$20.4 million through a private placement in connection with its public launch. According to CEO Oren Shuster, IMC does not need to raise any more capital.

He added that despite the current landscape for marijuana investments on Canadian exchanges, he thinks his company is arriving at a proper time given its long-term roadmap.

“If you talk about timing, if you’re looking for the short term — and if we were only a financial player — it’s the worst time to go public,” Shuster told the Investing News Network (INN). “Because we don’t have to raise more money, and we are not looking at the short term, I think that for us it doesn’t matter what is happening in the short term.”

Despite being based in Israel, IMC is pursuing a European play for its marijuana operations — including its current shipment of medical cannabis to Germany through its pharmaceutical distribution company Adjupharm, which IMC acquired in March.

The company is betting on the development of the European market as a powerhouse in the medical cannabis space, a concept that has been shared by fellow players with interests in the continent, despite snags such as exporting problems.

Shuster touted the different options his company offers to investors looking within the marijuana space, with its presence in Israel and Europe, compared to the Canadian market. Shuster commented that he doesn’t see his company adding operations in Canada anytime soon.

He said investors are tired of promises from cannabis companies and are looking for existing results.

“The sentiment is now very negative now in the market because people understand that the market in Canada, it’s starting to be very competitive and there’s a strong push in the prices, and the projections that many companies gave are not close to reality,” he told INN.

The executive added that the company plans to expand its assets in Europe to include operations in Portugal and Greece.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here:

Keep reading... Show less